Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 379 | 352 | 410 | 414 | 544 | 569 | 553 | 614 | 577 | 509 | 474 | 543 |
| Expenses | 371 | 360 | 408 | 408 | 513 | 528 | 488 | 547 | 525 | 471 | 455 | 445 |
| Operating Profit | 8 | -8 | 2 | 6 | 31 | 41 | 65 | 67 | 52 | 38 | 20 | 98 |
| OPM % | 2.0% | -2.2% | 0.5% | 1.4% | 6% | 7% | 12% | 11% | 9% | 7% | 4.2% | 18% |
| Other Income | 12 | 10 | 9 | 9 | 12 | 9 | 14 | 17 | 28 | 15 | 37 | 12 |
| Interest | 13 | 27 | 2 | 11 | 26 | 13 | 19 | 29 | 24 | 18 | 20 | 13 |
| Depreciation | 23 | 23 | 23 | 23 | 25 | 30 | 29 | 30 | 30 | 30 | 29 | 30 |
| Profit before tax | -16 | -48 | -14 | -19 | -9 | 7 | 31 | 24 | 26 | 4 | 7 | 67 |
| Tax % | -3% | -20% | 25% | -13% | 1% | 159% | 35% | 48% | 56% | 179% | -12% | 28% |
| Net Profit | -15 | -38 | -18 | -17 | -9 | -4 | 20 | 13 | 12 | -4 | 8 | 48 |
| EPS in Rs | -0.60 | -1.50 | -0.71 | -0.66 | -0.36 | -0.17 | 0.78 | 0.50 | 0.45 | -0.14 | 0.32 | 1.89 |
| Mar 2020 6m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 700 | 1,637 | 2,498 | 2,553 | 1,566 | 2,080 | 2,174 | 2,103 |
| Expenses | 595 | 1,353 | 2,119 | 2,211 | 1,586 | 1,936 | 1,996 | 1,896 |
| Operating Profit | 105 | 283 | 379 | 342 | -19 | 144 | 178 | 207 |
| OPM % | 15% | 17% | 15% | 13% | -1.2% | 7% | 8% | 10% |
| Other Income | 130 | 30 | 102 | 114 | 37 | 42 | 95 | 92 |
| Interest | 18 | 11 | 9 | 66 | 46 | 69 | 92 | 75 |
| Depreciation | 22 | 51 | 63 | 77 | 92 | 108 | 119 | 119 |
| Profit before tax | 194 | 252 | 409 | 313 | -121 | 9 | 62 | 105 |
| Tax % | 23% | 26% | 26% | 24% | -12% | 212% | 54% | |
| Net Profit | 150 | 186 | 304 | 238 | -106 | -11 | 29 | 64 |
| EPS in Rs | 29,914.00 | 37,296.00 | 11.97 | 9.35 | -4.17 | -0.42 | 1.13 | 2.52 |
| Dividend Payout % | 17% | 19% | 12% | 15% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 6% | -5% | -8% | ||
| Compounded Profit Growth | % | -31% | -49% | 241% | ||
| Stock Price CAGR | % | -14% | -11% | -30% | ||
| Return on Equity | % | 6% | -2% | 2% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 961 | 1,148 | 1,441 | 1,644 | 1,502 | 1,490 | 1,519 |
| Borrowings | 264 | 268 | 499 | 824 | 837 | 829 | 726 |
| Other Liabilities | 407 | 533 | 832 | 705 | 676 | 741 | 750 |
| Total Liabilities | 1,657 | 1,974 | 2,798 | 3,198 | 3,040 | 3,085 | 3,021 |
| Fixed Assets | 481 | 634 | 911 | 1,166 | 1,152 | 1,575 | 1,494 |
| CWIP | 101 | 112 | 188 | 356 | 521 | 83 | 87 |
| Investments | 191 | 304 | 211 | 183 | 114 | 3 | 5 |
| Other Assets | 885 | 924 | 1,487 | 1,494 | 1,253 | 1,425 | 1,435 |
| Total Assets | 1,657 | 1,974 | 2,798 | 3,198 | 3,040 | 3,085 | 3,021 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 22 | 333 | 65 | 204 | 250 | 66 | 222 |
| Cash from Investing Activity | 13 | -307 | -133 | -418 | -178 | 31 | -38 |
| Cash from Financing Activity | -26 | -14 | 58 | 234 | -85 | -91 | -190 |
| Net Cash Flow | 8 | 12 | -10 | 21 | -14 | 6 | -7 |
| Free Cash Flow | -49 | 124 | -177 | -259 | -14 | -20 | 178 |
| CFO/OP | 48% | 143% | 42% | 84% | -1,328% | 49% | 141% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 241 | 92 | 79 | 75 | 101 | 99 | 113 |
| Inventory Days | 271 | 152 | 161 | 158 | 185 | 173 | 145 |
| Days Payable | 209 | 137 | 144 | 108 | 176 | 159 | 149 |
| Cash Conversion Cycle | 302 | 106 | 96 | 124 | 109 | 113 | 110 |
| Working Capital Days | 152 | 57 | 57 | 53 | 28 | 20 | 10 |
| ROCE % | 19% | 24% | 16% | -3% | 3% | 7% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 49.32% | 49.32% | 49.32% | 49.32% | 49.33% | 49.33% | 49.41% | 48.98% | 48.98% | 48.98% | 48.95% | 48.95% |
| FIIs | 1.34% | 1.30% | 1.52% | 1.39% | 2.22% | 1.90% | 1.81% | 1.94% | 1.48% | 1.33% | 1.34% | 0.91% |
| DIIs | 0.61% | 0.26% | 0.20% | 0.20% | 0.42% | 0.27% | 0.48% | 0.37% | 0.00% | 0.00% | 0.00% | 0.00% |
| Government | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
| Public | 48.69% | 49.09% | 48.93% | 49.05% | 47.98% | 48.46% | 48.24% | 48.68% | 49.50% | 49.65% | 49.66% | 50.08% |
| No. of Shareholders | 1,40,672 | 1,40,829 | 1,52,703 | 1,46,010 | 1,28,875 | 1,27,392 | 1,26,617 | 1,28,082 | 1,31,853 | 1,35,031 | 1,34,841 | 1,35,999 |
Fundamentals
Market Cap₹ 1,458 Cr.
Current Price₹ 57.3
Stock P/E22.7
Book Value₹ 60.7
ROCE6.71 %
ROE1.90 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)-8%
Compounded Profit Growth (TTM)241%
Consolidated figures.
Valuation
Market capRs 1,402 Cr
Enterprise valueRs 2,193 Cr
P/E (TTM)21.82x
Price to book0.84x
Price to sales0.67x
EV / EBITDA7.33x
EV / EBIT12.17x
EV / sales1.04x
Price to cash flow6.86x
Earnings yield4.58%
Dividend yield2.54%
P/E, 3-year average8.51x
P/B, 3-year average1.50x
Profitability
Operating margin (excl. other income)13.38%
Operating margin (incl. other income)17.86%
EBITDA margin14.23%
Pre-tax margin4.98%
Net profit margin3.05%
Net margin, latest quarter8.88%
ROE15.16%
ROCE16.99%
ROA7.93%
ROE, 3-year average18.50%
ROCE, 3-year average20.36%
ROA, 3-year average10.32%
ROIC (approx.)5.56%
Tax rate24.08%
Other income / net worth6.85%
Growth
Sales growth (latest year)2.17%
Profit growth (latest year)-21.91%
Sales CAGR, 3 years53.95%
Profit CAGR, 3 years16.70%
Sales growth QoQ14.44%
Profit growth QoQ500.12%
Sales growth YoY (latest quarter)-11.54%
Profit growth YoY (latest quarter)280.05%
Per share
EPS (TTM)Rs 2.53
EPS (latest year)Rs 9.35
EPS (latest quarter)Rs 1.89
EPS, 3-year averageRs 9.55
Book value per shareRs 65.64
Sales per shareRs 82.70
Cash flow per shareRs 8.04
Free cash flow per shareRs 7.00
Dividend per share (latest year)Rs 1.40
Dividend per share, 3-year averageRs 1.40
Dividends
Dividend payout14.98%
Dividend payout, 3-year average15.25%
Efficiency
Asset turnover0.80x
Fixed asset turnover2.19x
Inventory turnover2.87x
Inventory days127 days
Debtor days75 days
Debtors turnover4.88x
Creditor days149 days
Cash conversion cycle110 days
Working capital days10 days
Leverage
Total debtRs 824 Cr
Cash and bankRs 33 Cr
Net debtRs 791 Cr
Debt to equity0.49x
Net debt / EBITDA2.64x
Interest coverage2.39x
Current ratio (filing 2026-03-31)1.07x
Quick ratio (filing 2026-03-31)0.64x
Trade payables (filing 2026-03-31)Rs 540 Cr
Owners' fund to total sources52.19%
Debt to assets25.76%
Cash flow
Cash from Operating Activity (latest year)Rs 204 Cr
Cash from Investing Activity (latest year)Rs -418 Cr
Cash from Financing Activity (latest year)Rs 234 Cr
Net Cash Flow (latest year)Rs 21 Cr
Free cash flow (latest year)Rs 178 Cr
FCFE (approx.: FCF + change in debt)Rs 503 Cr
Cash from ops / profit, 5 years1.78x
Sales to cash flow12.48x
Statement figures
Net sales (TTM)Rs 2,103 Cr
Net sales (latest year)Rs 2,553 Cr
Sales (latest quarter)Rs 543 Cr
Operating profit excl. other income (latest year)Rs 342 Cr
Operating profit (latest quarter)Rs 98 Cr
Other income (TTM)Rs 92 Cr
EBITDA (TTM)Rs 299 Cr
PBDT (TTM)Rs 224 Cr
Profit before tax (TTM)Rs 105 Cr
Tax (latest year)Rs 75 Cr
Net profit (TTM)Rs 64 Cr
Net profit (latest year)Rs 238 Cr
Net profit (latest quarter)Rs 48 Cr
Depreciation (TTM)Rs 119 Cr
Depreciation (latest quarter)Rs 30 Cr
Interest (TTM)Rs 75 Cr
Cost of goods sold (latest year)Rs 1,868 Cr
Total expenditure (latest year)Rs 2,211 Cr
Total income (latest year)Rs 2,667 Cr
Share capitalRs 25 Cr
ReservesRs 1,644 Cr
Shareholders' fundsRs 1,669 Cr
Total assetsRs 3,198 Cr
Net blockRs 1,166 Cr
Capital work in progressRs 356 Cr
InvestmentsRs 183 Cr
ReceivablesRs 523 Cr
InventoryRs 652 Cr
Other liabilitiesRs 705 Cr
Shares outstanding (crore)25.43
Ownership
Promoter holding48.95% (-0.03 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 21.8 is at the 57th percentile of its own 2.9-year range
(median 14.8, low 10.5, high 110.5).
P/B 0.84 is at the 7th percentile (median 1.72).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | MOL | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -7.4% | -2.8% | -4.7 pts |
| 1 month | -15.0% | -6.8% | -8.2 pts |
| 3 months | +15.7% | -7.6% | +23.3 pts |
| 6 months | +50.1% | +0.4% | +49.6 pts |
| 1 year | -34.0% | -9.9% | -24.0 pts |
| 2 years | -46.8% | -13.6% | -33.3 pts |
| 3 years | -31.1% | +14.2% | -45.3 pts |
| 5 years | -55.2% | +27.9% | -83.1 pts |
Red flags
F-score 3 of 8| explain | Debt up, profit down Borrowings up 65% while net profit fell in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹543 Cr -11.6% vs Jun 2025.
Net profit ₹48 Cr +269.2%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| UPL Ltd | 45,402 | 23.0 | 10.1 % |
| P I Industries Ltd | 34,725 | 32.2 | 15.0 % |
| Sumitomo Chemical India Ltd | 21,521 | 37.7 | 23.5 % |
| Bayer CropScience Ltd | 16,191 | 22.1 | 29.1 % |
| Sharda Cropchem Ltd | 6,509 | 10.4 | 30.2 % |
| Dhanuka Agritech Ltd | 4,148 | 15.5 | 23.8 % |
| Rallis India Ltd | 3,882 | 17.0 | 14.1 % |
| Bhagiradha Chemicals & Industries Ltd | 3,128 | 114 | 4.53 % |
| NACL Industries Ltd | 3,101 | 120 | 8.13 % |
| GSP Crop Science Ltd | 2,198 | 21.0 | 18.9 % |
| Insecticides India Ltd | 1,706 | 13.6 | 15.8 % |
| Bharat Rasayan Ltd | 1,673 | 12.0 | 16.1 % |
| Astec Lifesciences Ltd | 1,552 | -5.44 % | |
| India Pesticides Ltd | 1,533 | 14.2 | 16.6 % |
| Punjab Chemicals & Crop Protection Ltd | 1,283 | 19.2 | 18.6 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2023-06-20 | Annual General Meeting/Dividend - Rs 1.40 Per Share | |
| 2022-06-17 | Annual General Meeting/Dividend - Rs 1.40 Per Share | |
| 2021-09-15 | Annual General Meeting/Dividend - Rs 1.40 Per Sh |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Meghmani Organics Ltd?
Meghmani Organics Ltd (MOL) has a market capitalisation of Rs 1,458 Cr. at the 2026-10-01 close.
What is the P/E ratio of Meghmani Organics Ltd?
Meghmani Organics Ltd trades at a P/E of 22.7 on trailing twelve-month profit, at the 2026-10-01 close.
What were Meghmani Organics Ltd's latest quarterly results?
In the Jun 2026 quarter, Meghmani Organics Ltd sales was Rs 543 Cr (-11.6% vs Jun 2025) and net profit was Rs 48 Cr.
What is the 52-week high and low of Meghmani Organics Ltd?
The 52-week high is Rs 85.35 and the 52-week low is Rs 36.50.